A Passive Emerging Markets Allocation is an Active Position
Passive investors have inherited an unintended momentum bet, which reached a decade high in June.
Executive Summary
Emerging markets still look like a broad opportunity on paper, but despite its 1,165 constituents, the MSCI EM Index has the risk profile of a 28-security index.
The increase in concentration is a price event, not a change in index composition.
Passive investors have inherited an unintended momentum bet, which reached a decade high in June.
Concentration has a physical dimension: the rally has been led by asset-heavy chip fabricators, so how efficiently they use resources is one of the few things still separating them. For active investors, the opportunity has shifted towards stock selection among mega-caps and inefficiencies down the tail.
An emerging markets equity allocation used to provide diversification across a broad array of developing economies, often with a focus on traditional industries such as raw materials and manufacturing. That breadth remains, but it has become far less meaningful.
The MSCI Emerging Markets (EM) Index includes many markets that are considered developed economies, such as Taiwan and South Korea, which now make up 49% of the index, against China’s 20%. Those markets also house the companies driving the AI and semiconductor trade, and the index's risk now lies largely in the AI trade, rather than in the traditional heavier industries investors originally bought it for. Yet the AI trade is physical too: chip fabrication is among the most water and power-hungry manufacturing there is.
Concentration, measured by the Herfindahl-Hirschman Index (HHI), has vastly increased since 2022, leading to a decreased number of ‘effective names’ in the index. As of October 2026, despite its 1,165 constituents, the index has the appearance of an equally weighted 28-security index; the risk profile is dominated by a small number of names, with the long tail only contributing marginally to risk. Breadth has fallen sharply once before, in late 2020, due to concentration in Chinese internet platforms, and was partially restored through a subsequent 39% drawdown through 2021 and 2022. The recent pressure on markets has put this to the test. MSCI EM fell 8% in October and by early November was 16% below its June peak. This has done little to restore breadth, with the index being just as concentrated as it was before the drawdown.
MSCI EM - Effective Number of Names
The increase in concentration is driven by price, not structure
Concentration has not hurt returns. Investors in the MSCI EM have benefited from direct exposure to the most lucrative equity trade of the last few years through the very names now causing the concentration. Whether this is a structural change to the benchmark or a transient phase can be tested.
When decomposing the HHI increase into price movement and index changes, price accounts for almost all of it. However, in a market cap-weighted index, price changes should dominate, so that alone proves little. What is striking is that the index changes that occurred over the period (additions, deletions, float changes) have not added to concentration, and over time have reduced it, reflecting prices as opposed to benchmark reshaping.[1]
Concentration Driven by Price, Not Index Composition
Strong earnings and cyclical pricing
Price-driven does not mean unjustified; the top three constituents sit at genuine chokepoints of the global semiconductor supply chain. For Samsung Electronics and SK Hynix, earnings forecasts over the past year rose far faster than their share prices. However, the market treats memory profits as highly cyclical; the two trade at around 3x forward earnings against 17x for contract chipmaker TSMC. Therefore much of the index’s concentration rests on profits that are being priced as cyclical.
The character of the rally shows up in factor data too. Using MSCI's Barra GEMLT model, both the MSCI World and MSCI EM's largest names show what you'd expect from the leaders of a market cap-weighted index: profitable, high-beta, growth companies, but EM's also carry a momentum and residual volatility exposure, a classic signature of a rally.
MSCI EM and MSCI World Top 10 Securities - Factor Exposures
A single-theme bet
Concentration makes the index's style exposures more extreme. The momentum tilt of EM's largest names reached its highest level in over 10 years in June, whereas four years ago it was at the other extreme. A passive investor is therefore taking a sizeable momentum position without necessarily intending to. The effective number of names has fallen too, and with it the number of independent bets a systematic strategy can take.
A High Momentum Tilt
Portfolio construction
The narrowed index creates problems for both passive and active investing. Holding the index means holding around 90% of the index's stock-specific risk[2] in three companies, as well as taking a large bet on the memory-chip cycle and the index’s factor exposures. So whilst a passive allocation may contain no active risk to the underlying index, it is vastly different from traditional emerging market exposure.
This is not resolved simply by a correction. The two memory makers fell 31% and 46% respectively between June and October in local currency terms, yet the index barely broadened as the rest of the index fell too. Were the largest three names to fall 30% now, all else equal, effective names would only rise to around 44.
Moreover, the cost of not using an active risk budget effectively has risen. For most of the past decade, the index's largest names were more tightly clustered than the broader market. That relationship has inverted, with the top ten's returns now differing from one another more than the index's as a whole. Owning different securities within the theme leads to materially different outcomes.
Return Dispersion Has Migrated to the Top of the Index
What still separates them
Concentration has a physical dimension too. The rally has been led by asset-heavy fabrication companies. As at the end of October, over a third of the index's weighted average water intensity comes from TSMC, Samsung Electronics and SK Hynix – the physical manufacturing intensity that developed markets’ asset-light designers have typically outsourced to emerging markets.
Osmosis' Model of Resource Efficiency measures a company's carbon, water and waste usage against sector peers. As the index has concentrated into fabrication businesses, that measure has become more economically relevant. These companies have comparable business models but different input costs, both environmental and monetary.
Water rationing and power constraints are live operating risks. Companies do not carry these risks equally; in a cluster driven by a shared theme, that is one of the few things still separating them. In March 2021, a drought caused Taiwan to cut supply to two science parks in Taichung by 15%, forcing chipmakers such as TSMC and United Microelectronics to resort to trucking in water. Our research has found that since the start of our Emerging Markets dataset in August 2019, the Resource Efficiency signal has delivered 0.58% of annualised outperformance in EM attributable to the stock-specific factor, rather than simply taking advantage of factor or sector tilts.
The transformed opportunity
Down the rest of the index, the opposite condition holds. Capital and attention have followed the mega-caps, leaving a broad tail of over a thousand companies subject to less scrutiny each year. Although this tail doesn't dominate the risk profile of the index, it provides what active managers require: breadth and inefficiencies. Dispersion at the top rewards being right about a few large decisions, whereas breadth in the tail rewards being right slightly more often than not.
The opportunity in emerging markets is still present, but it has changed in both nature and location. Holding the index already takes an active position, and investors with a process, such as Resource Efficiency, that can tell these businesses apart as opposed to simply tracking the theme will still find the opportunity in the index.
[1] Share of index-level specific variance, calculated as (benchmark weight × specific risk)² per constituent as a proportion of the sum across all constituents, using Barra GEMLT specific risk estimates as at 31st October 2026. Specific returns are treated as uncorrelated across names, per the model's construction.
[2] Change in HHI (×10,000) decomposed into a price effect and a composition effect. Constituents at the start of each window are revalued by their own price return, with weights recomputed. The residual versus the actual end-period HHI is attributed to composition (additions, deletions, and changes in shares in issue or free float).
Important Information
This document is issued by Osmosis Investment Management UK Limited (“Osmosis UK”). Osmosis UK is an affiliate of Osmosis Investment Management US LLC (“Osmosis US”), Osmosis Investment Management NL B.V. (“Osmosis NL”) and Osmosis Investment Management AUS Pty Ltd (“Osmosis AUS”), and has been operating the Osmosis Model of Resource Efficiency. Osmosis UK is regulated by the FCA (Reference number: 765056). Osmosis US is regulated by the SEC. Osmosis NL is licensed as a manager of AIFs and authorised to provide discretionary portfolio management services and as such is subject to supervision by the Netherlands Authority for the Financial Markets under registration number 15006165. Osmosis UK, Osmosis US, and Osmosis AUS are wholly owned subsidiaries of Osmosis (Holdings) Limited (“OHL”).
This research is provided for information purposes and does not constitute an offer or solicitation of an offer or any advice or recommendation to purchase any securities. No representations, express or implied, are made as to the accuracy or completeness of such statements, assumptions, estimates or projections or with respect to any other materials herein.
The investment examples set forth in this presentation should not be considered a recommendation to buy or sell any specific securities. There can be no assurance that such investments will remain in the strategy. The case studies have been selected to be included in this presentation because we believe these are indicative of our strategy and investment process. Nothing herein shall be deemed to limit the investment strategies or investment opportunities to be pursued by Osmosis.
Our research identifies companies from the MSCI World or Emerging Market Index that report sufficiently on at least 2 of the following 3 metrics: carbon, water, and waste, to calculate a resource efficiency score for each reporting company – the Model of Resource Efficiency. Our Core strategies overweight efficient companies and underweight inefficient companies within each Osmosis defined sector, to remain sector neutral to each benchmark. Companies without a score are neutralised to benchmark weight. Our Active strategies invest only in efficient companies, outside of the Financial sector described below. Companies in the Financials sector are not given Resource Efficiency Scores. Certain strategies select Financials, based on complementary characteristics to the Resource Efficiency factor, for inclusion in the portfolio to maintain the portfolio’s overall factor weightings. All strategies exclude tobacco and companies that breach the UN Global Compact on social and governance safeguarding.
The historical index performance results for all benchmark indexes do not reflect the deduction of transaction, custodial, or management fees, the incurrence of which would have the effect of decreasing indicated historical performance results. Indexes are unmanaged and are not available for direct investment. The MSCI World Index captures large and mid cap representation across Developed Markets countries. The index covers approximately 85% of the free float-adjusted market capitalization in each country. The MSCI Emerging Markets Index captures large and mid-cap representation across 24 Emerging Markets (EM) countries. With 1,165 constituents, the index covers approximately 85% of the free float-adjusted market capitalization in each country.
The information contained in this document has been obtained by Osmosis from sources it believes to be reliable, but which have not been independently verified. Information contained in this document may comprise an internal analysis performed by Osmosis and be based on the subjective views of, and various assumptions made by, Osmosis at the date of this document. Osmosis does not warrant the relevance or correctness of the views expressed by it or its assumptions. Except in the case of fraudulent misrepresentation or as otherwise provided by applicable law, neither Osmosis nor any of its officers, employees or agents shall be liable to any person for any direct, indirect, or consequential loss arising from the use of this document.